Nava to receive US$ 50 Million as buy back proceeds from its Singapore Subsidiary, equivalent to around Rs. 450 crore
Singapore Subsidiary valued at US$ 1.26 Billion
Nava continues to hold 100% stake post buy-back
HYDERABAD, India, Jan. 5, 2026 /PRNewswire/ — Nava Ltd. (“the Company”) announced today that its Board accepted the proposal of buyback from Nava Global Pte Ltd., Singapore, (“NG”) its wholly-owned subsidiary.
NG, having considered its financial position, dividend distribution policy, capital commitments and cash flows, has decided to utilize the surplus cash to the extent of USD 50 Million for buyback of shares from the Company.
Strategic Rationale:
The buyback will achieve the following for Nava:
The buyback consideration was determined based on an independent fair equity value of NG at USD 1.26 Billion.
Summary of buyback transaction:
Management Commentary:
Ashwin Devineni, Managing Director and CEO, commented:
“This transaction underscores our focus on disciplined capital allocation and long-term value creation. By unlocking capital from a mature subsidiary and redeploying it in line with our strategic priorities, we are improving capital efficiency, optimising returns, and enhancing shareholder value, while maintaining the financial strength and growth prospects of our businesses.”
About Nava Limited
Founded in 1972, Nava Limited is a publicly listed multinational corporation with interests in metals, energy, mining, healthcare, and commercial agriculture. As one of India’s leading ferroalloy producers, Nava also operates Zambia’s largest mine-to-mouth power plant. Expanding its global presence, Nava is investing in commercial agriculture in Zambia and in healthcare in Southeast Asia. For more information, please visit www.navalimited.com.
For More Information, Contact:
Mr. VSN Raju
Company Secretary and Vice President
Nava Limited
Tel: +91-4023403501 / +91-4067283333
Email: investorservices@navalimited.com
Media Contact:
Ms. Lisa Rufus G.
Phone: +91-9154240656
Email: lisa.r@navalimited.com
Logo: https://mma.prnewswire.com/media/2854361/Nava_Limited_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/nava-announces-us-50-million-buyback-proceeds-from-wholly-owned-subsidiary-singapore-302652620.html
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…
Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…
June 05, 2026 19:30 ET | Source: Oban BioPharma, Inc. STAMFORD, Conn., June 05, 2026…
Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and…